| DAA1973 |
5-hmC increase in cerebrellum |
Molecular |
cerebellum |
Mouse |
— |
— |
|
| DAA1 |
abhydrolase domain containing 14A |
Molecular |
brain |
Human |
ABHD14A |
3.0% Decrease Gene Expression Level |
|
| DAA1944 |
Ability to acquire motor skills decreases |
Psychological |
brain |
Mouse |
— |
— |
|
| DAA2 |
abl-interactor 2 |
Molecular |
brain |
Human |
ABI2 |
18.0% Decrease Gene Expression Level |
|
| DAA723 |
Accumulation of extracellular neuritic plaques |
Physiological |
brain |
Human |
— |
— |
|
| DAA722 |
Accumulation of neuromelanin in dopaminergic nigral neurons |
Physiological |
substantia nigra |
Human |
— |
— |
|
| DAA3 |
actin, alpha 1, skeletal muscle |
Molecular |
brain |
Human |
ACTA1 |
16.0% Decrease Gene Expression Level |
|
| DAA4 |
actin, beta |
Molecular |
brain |
Human |
ACTB |
4.0% Decrease Gene Expression Level |
|
| DAA5 |
actin-like 6A |
Molecular |
brain |
Human |
ACTL6A |
21.0% Increase Gene Expression Level |
|
| DAA761 |
Activation threshold for long-term potentiation is increased |
Psychological |
brain |
Human |
— |
— |
|
| DAA618 |
Acute rheumatic fever and chronic rheumatic heart diseases |
Pathological |
heart, skin, brain |
Human |
— |
SeriesMorbidity |
|
| DAA1391 |
acyl-CoA synthetase short-chain family member 1 |
Molecular |
hippocampus |
Mouse |
Acss1 |
2.0% Decrease Gene Expression Level |
|
| DAA12 |
adaptor-related protein complex 1, sigma 1 subunit |
Molecular |
brain |
Human |
AP1S1 |
12.0% Decrease Gene Expression Level |
|
| DAA1978 |
Age differences in classical conditioning of the eyelid response |
Physiological |
eyelid |
Human |
— |
— |
|
| DAA6 |
AHNAK nucleoprotein |
Molecular |
brain |
Human |
AHNAK |
13.0% Increase Gene Expression Level |
|
| DAA1247 |
albumin |
Molecular |
brain |
Mouse |
Alb |
88.0% Increase Gene Expression Level |
|
| DAA7 |
aldehyde dehydrogenase 9 family, member A1 |
Molecular |
brain |
Human |
ALDH9A1 |
10.0% Increase Gene Expression Level |
|
| DAA1277 |
aldo-keto reductase family 1, member C18 |
Molecular |
cochlea |
Mouse |
Akr1c18 |
20.0% Decrease Gene Expression Level |
|
| DAA1967 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression increase |
Molecular |
cerebellum |
Mouse |
— |
— |
|
| DAA1966 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase |
Molecular |
hippocampus |
Mouse |
— |
— |
|
| DAA1964 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase |
Molecular |
cerebellum |
Mouse |
Alox5 |
— |
|
| DAA2033 |
Alterations in structural proteins and cell membranes in the lenses |
Physiological |
lens |
Human |
— |
— |
|
| DAA2041 |
Altered brain mitochondrial metabolism |
Physiological |
brain |
Human |
— |
— |
|
| DAA2031 |
Altered concentration of sodium, potassium and calcium |
Physiological |
lens |
Human |
— |
— |
|
| DAA748 |
Altered sleep parameters and patterns |
Psychological |
brain |
Human |
— |
— |
|